首页 > 市场调查报告书 > 医疗设备

美容整形

市场调查报告书

商品编码

1542621

全球肉毒桿菌毒素市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势和预测

Global Botulinum Toxin Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年07月01日 | 出版商:

Value Market Research | 英文 161 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录图表

全球肉毒桿菌毒素市场需求预计将从 2023 年的 159.9 亿美元达到近 390.2 亿美元的市场规模，2024-2032 年研究期间复合年增长率为 10.42%。

肉毒桿菌毒素（BTX）是由肉毒桿菌产生的中性毒素。它是一种剧毒物质，会抑制乙酰胆碱的释放，乙酰胆碱是一种可能导致弛缓性麻痹的神经传导物质。肉毒桿菌毒素的主要用途是在医学上治疗患者的神经性疼痛、慢性偏头痛、过度疼痛和过度活跃的肌肉运动相关疾病。此外，它还可用于化妆品应用，透过放鬆肌肉来减少脸部皱纹

市场动态

偏头痛、肌肉痉挛及相关病症的盛行率不断增加，推动了对肉毒桿菌毒素的需求。对减少住院时间、更快康復和小切口的微创治疗的需求不断增长，也推动了产品需求的上升。人们将焦点转向增强视觉吸引力，这增加了化妆品应用中对肉毒桿菌的需求。然而，该产品的高成本以及与肉毒桿菌的使用相关的副作用可能会抑制其需求。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具也对全球肉毒桿菌毒素市场的各个细分市场进行了包容性评估。肉毒桿菌毒素产业的成长和趋势为本研究提供了整体方法。

市场区隔

肉毒桿菌毒素市场报告的这一部分提供了国家和区域层面细分市场的详细资料，从而帮助策略师确定相应产品或服务的目标人群以及即将到来的机会。

依产品类型

A 型（Botox、Dysport、Xeomin、其他）
B型

按申请

治疗（慢性偏头痛、膀胱过动症、颈肌张力失调、痉挛等）
美学（眉间纹、鱼尾纹、额头纹等）

按最终用途

医院
皮肤科诊所
美容中心及医疗水疗中心

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲肉毒桿菌毒素市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。肉毒桿菌市场的主要参与者包括Ipsen Group、Allergen Inc.、Medi-Tox Inc.、Merz Pharma、US Worldmeds、Evolus、Galderma、Metabiologics Inc.、兰州生物製品研究所。本节包含竞争格局的整体视图，包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

区域展望
介绍
北美销售分析
- 概览、历史与预测资料销售分析
- 北美按细分市场销售分析
- 北美按国家销售分析
- 美国销售分析
- 加拿大销售分析
- 墨西哥销售分析
欧洲销售分析
- 概览、历史与预测资料销售分析
- 欧洲按细分市场销售分析
- 欧洲按国家销售分析
- 英国销售分析
- 法国销售分析
- 德国销售分析
- 义大利销售分析
- 俄罗斯销售分析
- 欧洲其他地区销售分析
亚太地区销售分析
- 概览、历史与预测资料销售分析
- 亚太地区按细分市场销售分析
- 亚太地区按国家销售分析
- 中国销售分析
- 印度销售分析
- 日本销售分析
- 韩国销售分析
- 澳洲销售分析
- 东南亚销售分析
- 亚太地区其他地区销售分析
拉丁美洲销售分析
- 概览、历史与预测资料销售分析
- 拉丁美洲按细分市场销售分析
- 拉丁美洲按国家销售分析
- 巴西销售分析
- 阿根廷销售分析
- 秘鲁销售分析
- 智利销售分析
- 拉丁美洲其他地区销售分析
中东和非洲销售分析
- 概览、历史与预测资料销售分析
- 中东和非洲按细分市场销售分析
- 中东和非洲按国家销售分析
- 沙乌地阿拉伯销售分析
- 阿联酋销售分析
- 以色列销售分析
- 南非销售分析
- 中东其他地区和非洲销售分析

第 9 章：肉毒桿菌毒素公司的竞争格局

肉毒毒素市场竞争
伙伴关係/协作/协议
併购
新产品发布
其他发展

第 10 章：公司简介

顶级公司市占率分析
市场集中度
Ipsen Group

公司概况
公司收入
产品
最新动态

Allergen Inc.

公司概况
公司收入
产品
最新动态

Medy-Tox Inc.

公司概况
公司收入
产品
最新动态

Merz Pharma

公司概况
公司收入
产品
最新动态

US Worldmeds

公司概况
公司收入
产品
最新动态

Evolus

公司概况
公司收入
产品
最新动态

Galderma

公司概况
公司收入
产品
最新动态

Metabiologics Inc.

公司概况
公司收入
产品
最新动态

Lanzhou Institute Of Biological Products

公司概况
公司收入
产品
最新动态

註 - 在公司概况中，财务详细资讯和最新发展视情况而定，或对私人公司而言可能不包括在内

简介目录图表

Product Code: VMR11210936

The global demand for Botulinum Toxin Market is presumed to reach the market size of nearly USD 39.02 Billion by 2032 from USD 15.99 Billion in 2023 with a CAGR of 10.42% under the study period 2024-2032.

Botulinum toxin (BTX) is the neutrotoxin produced by bacterium Clostridium botulinum. It is a highly poisonous substance that inhibits the release of acetylcholine, a neurotransmitter that may cause flaccid paralysis. The prominent use of botulinum toxin is in medicine to cure the patient from neuropathic pain, chronic migraine, excessive pain, and overactive muscle movement related disorders. In addition, it can be used in cosmetics applications, for reducing facial wrinkles by relaxing the muscles

MARKET DYNAMICS

Increasing prevalence of migraine, muscle spasticity & related conditions is driving the demand for the botulinum toxin. The growing demand of minimally invasive treatments for reducing hospital stays, faster recovery, and small incision is also pushing the product demand higher. The shifting focus towards enhancing visual appeal has increased the demand for botulinum toxin in cosmetic application. However, the high cost of the product with side effects associated with the usage of botulinum toxin may curb its demand.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Botulinum Toxin. The growth and trends of Botulinum Toxin industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Botulinum Toxin market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product Type

Type A (Botox, Dysport, Xeomin, Others)
Type B

By Application

Therapeutic (Chronic Migraine, Overactive Bladder, Cervical Dystonia, Spasticity, Others)
Aesthetic (Glabellar Lines, Crow's Feet, Forehead Lines, Others)

By End-use

Hospitals
Dermatology Clinics
Cosmetic Centers And Medspas

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Botulinum Toxin market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Botulinum Toxin market include Ipsen Group, Allergen Inc., Medy-Tox Inc., Merz Pharma, US Worldmeds, Evolus, Galderma, Metabiologics Inc., Lanzhou Institute Of Biological Products. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. BOTULINUM TOXIN - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product Type
- 3.7.2 Market Attractiveness Analysis By Application
- 3.7.3 Market Attractiveness Analysis By End-use
- 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL BOTULINUM TOXIN MARKET ANALYSIS BY PRODUCT TYPE

5.1. Overview By Product Type
5.2. Historical and Forecast Data Analysis By Product Type
5.3. Type A (Botox, Dysport, Xeomin, Others) Historic and Forecast Sales By Regions
5.4. Type B Historic and Forecast Sales By Regions

6. GLOBAL BOTULINUM TOXIN MARKET ANALYSIS BY APPLICATION

6.1. Overview By Application
6.2. Historical and Forecast Data Analysis By Application
6.3. Therapeutic (Chronic Migraine, Overactive Bladder, Cervical Dystonia, Spasticity, Others) Historic and Forecast Sales By Regions
6.4. Aesthetic (Glabellar Lines, Crow's Feet, Forehead Lines, Others) Historic and Forecast Sales By Regions

7. GLOBAL BOTULINUM TOXIN MARKET ANALYSIS BY END-USE

7.1. Overview By End-use
7.2. Historical and Forecast Data Analysis By End-use
7.3. Hospitals Historic and Forecast Sales By Regions
7.4. Dermatology Clinics Historic and Forecast Sales By Regions
7.5. Cosmetic Centers And Medspas Historic and Forecast Sales By Regions

8. GLOBAL BOTULINUM TOXIN MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1 Overview, Historic and Forecast Data Sales Analysis
- 8.3.2 North America By Segment Sales Analysis
- 8.3.3 North America By Country Sales Analysis
- 8.3.4 United States Sales Analysis
- 8.3.5 Canada Sales Analysis
- 8.3.6 Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1 Overview, Historic and Forecast Data Sales Analysis
- 8.4.2 Europe By Segment Sales Analysis
- 8.4.3 Europe By Country Sales Analysis
- 8.4.4 United Kingdom Sales Analysis
- 8.4.5 France Sales Analysis
- 8.4.6 Germany Sales Analysis
- 8.4.7 Italy Sales Analysis
- 8.4.8 Russia Sales Analysis
- 8.4.9 Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1 Overview, Historic and Forecast Data Sales Analysis
- 8.5.2 Asia Pacific By Segment Sales Analysis
- 8.5.3 Asia Pacific By Country Sales Analysis
- 8.5.4 China Sales Analysis
- 8.5.5 India Sales Analysis
- 8.5.6 Japan Sales Analysis
- 8.5.7 South Korea Sales Analysis
- 8.5.8 Australia Sales Analysis
- 8.5.9 South East Asia Sales Analysis
- 8.5.10 Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1 Overview, Historic and Forecast Data Sales Analysis
- 8.6.2 Latin America By Segment Sales Analysis
- 8.6.3 Latin America By Country Sales Analysis
- 8.6.4 Brazil Sales Analysis
- 8.6.5 Argentina Sales Analysis
- 8.6.6 Peru Sales Analysis
- 8.6.7 Chile Sales Analysis
- 8.6.8 Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1 Overview, Historic and Forecast Data Sales Analysis
- 8.7.2 Middle East & Africa By Segment Sales Analysis
- 8.7.3 Middle East & Africa By Country Sales Analysis
- 8.7.4 Saudi Arabia Sales Analysis
- 8.7.5 UAE Sales Analysis
- 8.7.6 Israel Sales Analysis
- 8.7.7 South Africa Sales Analysis
- 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE BOTULINUM TOXIN COMPANIES

9.1. Botulinum Toxin Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10. COMPANY PROFILES OF BOTULINUM TOXIN INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. Ipsen Group
- 10.3.1 Company Overview
- 10.3.2 Company Revenue
- 10.3.3 Products
- 10.3.4 Recent Developments
10.4. Allergen Inc.
- 10.4.1 Company Overview
- 10.4.2 Company Revenue
- 10.4.3 Products
- 10.4.4 Recent Developments
10.5. Medy-Tox Inc.
- 10.5.1 Company Overview
- 10.5.2 Company Revenue
- 10.5.3 Products
- 10.5.4 Recent Developments
10.6. Merz Pharma
- 10.6.1 Company Overview
- 10.6.2 Company Revenue
- 10.6.3 Products
- 10.6.4 Recent Developments
10.7. US Worldmeds
- 10.7.1 Company Overview
- 10.7.2 Company Revenue
- 10.7.3 Products
- 10.7.4 Recent Developments
10.8. Evolus
- 10.8.1 Company Overview
- 10.8.2 Company Revenue
- 10.8.3 Products
- 10.8.4 Recent Developments
10.9. Galderma
- 10.9.1 Company Overview
- 10.9.2 Company Revenue
- 10.9.3 Products
- 10.9.4 Recent Developments
10.10. Metabiologics Inc.
- 10.10.1 Company Overview
- 10.10.2 Company Revenue
- 10.10.3 Products
- 10.10.4 Recent Developments
10.11. Lanzhou Institute Of Biological Products
- 10.11.1 Company Overview
- 10.11.2 Company Revenue
- 10.11.3 Products
- 10.11.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

简介目录图表

LIST OF TABLES

Market Snapshot
Drivers: Impact Analysis
Restraints: Impact Analysis
List of Raw Material
List of Raw Material Manufactures
Analysis By Product Type (USD MN)
Type A (Botox, Dysport, Xeomin, Others) Market Sales By Geography (USD MN)
Type B Market Sales By Geography (USD MN)
Analysis By Application (USD MN)
Therapeutic (Chronic Migraine, Overactive Bladder, Cervical Dystonia, Spasticity, Others) Market Sales By Geography (USD MN)
Aesthetic (Glabellar Lines, Crow's Feet, Forehead Lines, Others) Market Sales By Geography (USD MN)
Analysis By End-use (USD MN)
Hospitals Market Sales By Geography (USD MN)
Dermatology Clinics Market Sales By Geography (USD MN)
Cosmetic Centers And Medspas Market Sales By Geography (USD MN)
Global Botulinum Toxin Market Sales By Geography (USD MN)
North America Market Analysis (USD MN)
United States Market Analysis (USD MN)
Canada Market Analysis (USD MN)
Mexico Market Analysis (USD MN)
Europe Market Analysis (USD MN)
Europe Market Estimate By Country (USD MN)
United Kingdom Market Analysis (USD MN)
France Market Analysis (USD MN)
Germany Market Analysis (USD MN)
Italy Market Analysis (USD MN)
Russia Market Analysis (USD MN)
Spain Market Analysis (USD MN)
Rest of Europe Market Analysis (USD MN)
Asia Pacific Market Analysis (USD MN)
China Market Analysis (USD MN)
Japan Market Analysis (USD MN)
India Market Analysis (USD MN)
South Korea Market Analysis (USD MN)
Australia Market Analysis (USD MN)
South East Asia Market Analysis (USD MN)
Rest of Asia Pacific Market Analysis (USD MN)
Latin America Market Analysis (USD MN)
Brazil Market Analysis (USD MN)
Argentina Market Analysis (USD MN)
Peru Market Analysis (USD MN)
Chile Market Analysis (USD MN)
Rest of Latin America Market Analysis (USD MN)
Middle East & Africa Market Analysis (USD MN)
Saudi Arabia Market Analysis (USD MN)
UAE Market Analysis (USD MN)
Israel Market Analysis (USD MN)
South Africa Market Analysis (USD MN)
Rest of Middle East and Africa Market Analysis (USD MN)
Partnership/Collaboration/Agreement
Mergers And Acquisition

LIST OF FIGURES

Research Scope of Botulinum Toxin Report
Market Research Process
Market Research Methodology
Global Botulinum Toxin Market Size, By Region (USD MN)
Porters Five Forces Analysis
Market Attractiveness Analysis By Product Type
Market Attractiveness Analysis By Application
Market Attractiveness Analysis By End-use
Market Attractiveness Analysis By Region
Value Chain Analysis
Global Market Analysis By Product Type (USD MN)
Type A (Botox, Dysport, Xeomin, Others) Market Sales By Geography (USD MN)
Type B Market Sales By Geography (USD MN)
Global Market Analysis By Application (USD MN)
Therapeutic (Chronic Migraine, Overactive Bladder, Cervical Dystonia, Spasticity, Others) Market Sales By Geography (USD MN)
Aesthetic (Glabellar Lines, Crow's Feet, Forehead Lines, Others) Market Sales By Geography (USD MN)
Global Market Analysis By End-use (USD MN)
Hospitals Market Sales By Geography (USD MN)
Dermatology Clinics Market Sales By Geography (USD MN)
Cosmetic Centers And Medspas Market Sales By Geography (USD MN)
Global Market Sales (USD MN)
North America Market Sales (USD MN)
Europe Market Sales (USD MN)
Asia Pacific Market Sales (USD MN)
Latin America Market Sales (USD MN)
Middle East & Africa Market Sales (USD MN)
Recent Development in Industry
Top Company Market Share Analysis